64 related articles for article (PubMed ID: 8565150)
1. Microdensitometric measures of cytoplasmic RNA and total protein in pyramidal neurons of the insular cortex and midfrontal gyrus in patients with Alzheimer's disease.
Colurso GJ; Kan RK; Anthony A
Cell Biochem Funct; 1995 Dec; 13(4):287-92. PubMed ID: 8565150
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical phenotype of corticocortical connections in the macaque monkey: quantitative analysis of a subset of neurofilament protein-immunoreactive projection neurons in frontal, parietal, temporal, and cingulate cortices.
Hof PR; Nimchinsky EA; Morrison JH
J Comp Neurol; 1995 Nov; 362(1):109-33. PubMed ID: 8576425
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of neuronal lipofuscin in the superior temporal gyrus in Alzheimer's disease do not differ from non-diseased controls: a comparison with disease-related changes in the superior frontal gyrus.
Mountjoy CQ; Dowson JH; Harrington C; Cairns MR; Wilton-Cox H
Acta Neuropathol; 2005 May; 109(5):490-6. PubMed ID: 15759127
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease.
Colurso GJ; Nilson JE; Vervoort LG
Life Sci; 2003 Aug; 73(14):1795-803. PubMed ID: 12888118
[TBL] [Abstract][Full Text] [Related]
5. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
Doebler JA; Markesbery WR; Anthony A; Davies P; Scheff SW; Rhoads RE
Ann Neurol; 1988 Jan; 23(1):20-4. PubMed ID: 2449843
[TBL] [Abstract][Full Text] [Related]
6. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
7. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.
Sampson VL; Morrison JH; Vickers JC
Exp Neurol; 1997 May; 145(1):295-302. PubMed ID: 9184132
[TBL] [Abstract][Full Text] [Related]
8. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.
Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM
Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204
[TBL] [Abstract][Full Text] [Related]
9. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU
Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742
[TBL] [Abstract][Full Text] [Related]
10. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
Muma NA; Mariyappa R; Williams K; Lee JM
Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Greber S; Lubec G; Cairns N; Fountoulakis M
Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
[TBL] [Abstract][Full Text] [Related]
12. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
13. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
Korolainen MA; Goldsteins G; Nyman TA; Alafuzoff I; Koistinaho J; Pirttilä T
Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
[TBL] [Abstract][Full Text] [Related]
14. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex.
Lian Q; Ladner CJ; Magnuson D; Lee JM
Exp Neurol; 2001 Jan; 167(1):158-65. PubMed ID: 11161603
[TBL] [Abstract][Full Text] [Related]
15. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
Spiechowicz M; Bernstein HG; Dobrowolny H; Leśniak W; Mawrin C; Bogerts B; Kuźnicki J; Filipek A
Neurochem Int; 2006 Oct; 49(5):487-93. PubMed ID: 16698122
[TBL] [Abstract][Full Text] [Related]
16. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.
Bussière T; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR
J Comp Neurol; 2003 Aug; 463(3):281-302. PubMed ID: 12820162
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
Kumar U; Patel SC
Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
[TBL] [Abstract][Full Text] [Related]
20. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
Barrachina M; Maes T; Buesa C; Ferrer I
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):505-16. PubMed ID: 16972884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
